08/08/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
8:44 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:32 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
4:42 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | Gover Justin D. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:42 PM | Machado Patrick (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/05/2024
4:43 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:41 PM | Svoronos Dawn (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:41 PM | Cannon Gillian (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
4:30 PM | PIMSTONE SIMON N. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:22 PM | Xenon Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024
3:12 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:09 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:26 PM | Xenon Pharmaceuticals (Filer)
| Form DEF 14A | |
04/19/2024
3:21 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
5:41 PM | AULIN SHERRY (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:42 PM | Von Seggern Christopher (Reporting)
Xenon Pharmaceuticals (Issuer)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:33 PM | MORTIMER IAN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:34 PM | DiFabio Andrea (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:35 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:37 PM | EMPFIELD JAMES R. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | KENNEY CHRISTOPHER JOHN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:09 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:47 PM | GAROFALO ELIZABETH A. (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:27 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
4:28 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:31 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
6:03 PM | GANNON STEVEN (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
6:04 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
3:10 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:12 AM | Avoro Capital Advisors LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
6:43 AM | DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/02/2024
3:41 PM | ROBIN SHERRINGTON (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
4:04 PM | AZAB MOHAMMAD (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:50 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4/A | |
12/15/2023
4:38 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:02 PM | PATOU GARY (Reporting)
Xenon Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
4:05 PM | Xenon Pharmaceuticals (Filer)
| Form 424B5 | |
Who are Nvidia’s New Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” |
11/27/2023
6:03 AM | Xenon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
